Restricting Online Sales and Reclassifying E-Cigarettes as Prescription-Only: A Public Health Policy Perspective

限制电子烟网络销售并将其重新归类为处方药:公共卫生政策视角

阅读:1

Abstract

The widespread use of electronic cigarettes, particularly among adolescents and young adults in the United States, has emerged as a critical public health challenge. Despite existing federal regulations, online access remains a significant channel for underage use, largely due to inconsistent enforcement of age verification. Although only about 2% of underage e-cigarette users report purchasing them online, more than three-quarters of online vendors allow checkout without verifying age, and test purchases frequently bypass identity checks, with nearly 70% resulting in delivery without age confirmation. E-cigarettes have been associated with numerous adverse health outcomes, including cardiovascular, respiratory, and neurological conditions. This editorial advocates for two urgent policy measures: a federal prohibition on the online sale of electronic nicotine delivery systems and the reclassification of these products as prescription-only. These steps would enhance regulatory oversight, limit youth access, and support evidence-based smoking cessation efforts under professional supervision. Implementing such reforms would strengthen public health protections, reduce healthcare costs, and promote long-term population well-being.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。